Dr Peter Jackson, executive director of the AMR Centre explains why a new clinical trial taking place in the UK could represent a major step forward in the fight against antimicrobial resistance (AMR).
There is rising tide of drug-resistant microbes that is thought of as one of the greatest threats to public health today, yet the pipeline of new antibiotics is dwindling. Here, Dr Peter Jackson, AMR Centre, discusses what action is needed
